- News & Research
- CBONDS ALT
Allergan, plc (formerly Actavis plc) is a global, integrated specialty pharmaceutical company. The Company focused on developing, manufacturing and distributing generic, brand and biosimilar products. The Company produces and markets generic, branded generic, branded and over-the-counter (OTC) pharmaceutical products covering all therapeutic classes. The Company's product formulations include modified release, solid oral dosage, semi-solids, suspensions, transdermals, suppositories, creams, ointments, liquids and injectables.
|02/06/2020||S&P Global Ratings withdrew Local Currency LT credit rating for Allergan|
|02/06/2020||S&P Global Ratings withdrew Foreign Currency LT credit rating for Allergan|
|14/05/2020||Fitch Ratings withdrew LT Int. Scale (foreign curr.) credit rating for Allergan|
|14/05/2020||Fitch Ratings upgrades LT Int. Scale (foreign curr.) credit rating of Allergan to "BBB" from "BBB-"; outlook positive|
|11/05/2020||S&P Global Ratings upgrades Foreign Currency LT credit rating of Allergan to "BBB+" from "BBB"; outlook stable|